141 related articles for article (PubMed ID: 7643882)
1. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators.
Serruys PW; Herrman JP; Simon R; Rutsch W; Bode C; Laarman GJ; van Dijk R; van den Bos AA; Umans VA; Fox KA
N Engl J Med; 1995 Sep; 333(12):757-63. PubMed ID: 7643882
[TBL] [Abstract][Full Text] [Related]
2. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
Cohen M; Demers C; Gurfinkel EP; Turpie AG; Fromell GJ; Goodman S; Langer A; Califf RM; Fox KA; Premmereur J; Bigonzi F
N Engl J Med; 1997 Aug; 337(7):447-52. PubMed ID: 9250846
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of once daily parnaparin and unfractionated heparin in unstable angina pectoris: PRIME CARE study.
PRIME CARE Study Investigators Group
Indian Heart J; 2005; 57(6):648-54. PubMed ID: 16521631
[TBL] [Abstract][Full Text] [Related]
4. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group.
Serruys PW; de Jaegere P; Kiemeneij F; Macaya C; Rutsch W; Heyndrickx G; Emanuelsson H; Marco J; Legrand V; Materne P
N Engl J Med; 1994 Aug; 331(8):489-95. PubMed ID: 8041413
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of hirudin in reducing cardiovascular events in patients with acute coronary syndrome undergoing early percutaneous coronary intervention.
Mehta SR; Eikelboom JW; Rupprecht HJ; Lewis BS; Natarajan MK; Yi C; Pogue J; Yusuf S
Eur Heart J; 2002 Jan; 23(2):117-23. PubMed ID: 11785993
[TBL] [Abstract][Full Text] [Related]
6. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
[TBL] [Abstract][Full Text] [Related]
7. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators.
Bittl JA; Strony J; Brinker JA; Ahmed WH; Meckel CR; Chaitman BR; Maraganore J; Deutsch E; Adelman B
N Engl J Med; 1995 Sep; 333(12):764-9. PubMed ID: 7643883
[TBL] [Abstract][Full Text] [Related]
8. Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group.
Verin V; Popowski Y; de Bruyne B; Baumgart D; Sauerwein W; Lins M; Kovacs G; Thomas M; Calman F; Disco C; Serruys PW; Wijns W;
N Engl J Med; 2001 Jan; 344(4):243-9. PubMed ID: 11172150
[TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.
Lancet; 1999 Feb; 353(9151):429-38. PubMed ID: 9989712
[TBL] [Abstract][Full Text] [Related]
10. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
[TBL] [Abstract][Full Text] [Related]
11. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators.
Savage MP; Douglas JS; Fischman DL; Pepine CJ; King SB; Werner JA; Bailey SR; Overlie PA; Fenton SH; Brinker JA; Leon MB; Goldberg S
N Engl J Med; 1997 Sep; 337(11):740-7. PubMed ID: 9287229
[TBL] [Abstract][Full Text] [Related]
12. [Coronary angioplasty in unstable angina at rest. Influence of the degree of clinical instability on the immediate and long-term results].
Cavallini C; Olivari Z; Risica G; Cannarozzo PP; Marton F; Grisolia EF; Giommi L; Stritoni P
G Ital Cardiol; 1996 Jun; 26(6):647-55. PubMed ID: 8803586
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events.
O'Neill WW; Serruys P; Knudtson M; van Es GA; Timmis GC; van der Zwaan C; Kleiman J; Gong J; Roecker EB; Dreiling R; Alexander J; Anders R
N Engl J Med; 2000 May; 342(18):1316-24. PubMed ID: 10793164
[TBL] [Abstract][Full Text] [Related]
14. Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina.
Rupprecht HJ; Terres W; Ozbek C; Luz M; Jessel A; Hafner G; vom Dahl J; Kromer EP; Prellwitz W; Meyer J
J Am Coll Cardiol; 1995 Dec; 26(7):1637-42. PubMed ID: 7594097
[TBL] [Abstract][Full Text] [Related]
15. Reduced acute thrombus formation results in decreased neointimal proliferation after coronary angioplasty.
Unterberg C; Sandrock D; Nebendahl K; Buchwald AB
J Am Coll Cardiol; 1995 Dec; 26(7):1747-54. PubMed ID: 7594113
[TBL] [Abstract][Full Text] [Related]
16. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.
Schwartz L; Bourassa MG; Lespérance J; Aldridge HE; Kazim F; Salvatori VA; Henderson M; Bonan R; David PR
N Engl J Med; 1988 Jun; 318(26):1714-9. PubMed ID: 2967433
[TBL] [Abstract][Full Text] [Related]
17. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
[TBL] [Abstract][Full Text] [Related]
18. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes.
Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators
N Engl J Med; 1996 Sep; 335(11):775-82. PubMed ID: 8778585
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of recombinant hirudin (CGP 39,393/TMREVASC) in the prevention of restenosis after percutaneous transluminal coronary angioplasty. Rationale and design of the HELVETICA trial, a multicentre randomized double blind heparin controlled study.
Herrman JP; Simon R; Umans VA; Peerboom PF; Keane D; Rijnierse JJ; Bach D; Kobi P; Kerry R; Close P
Eur Heart J; 1995 Nov; 16 Suppl L():56-62. PubMed ID: 8869020
[TBL] [Abstract][Full Text] [Related]
20. Reactivation of unstable angina after the discontinuation of heparin.
Théroux P; Waters D; Lam J; Juneau M; McCans J
N Engl J Med; 1992 Jul; 327(3):141-5. PubMed ID: 1608405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
